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The human homologue of Caenorhabditis elegans CED-6
specifically promotes phagocytosis of apoptotic cells
Elke Smits*, Wim Van Criekinge*, Geert Plaetinck and Thierry Bogaert
A key feature of the process of programmed cell death
(apoptosis) is the efficiency with which the dying cells
are recognized and engulfed by phagocytes [1].
Apoptotic cells are rapidly cleared either by neighbouring
cells acting as semi-professional phagocytes or by
experts of the macrophage line, so that an inflammatory
response is avoided [2]. The Caenorhabditis elegans
gene ced-6 is required for efficient engulfment of
apoptotic cells [3] and is one of a group of genes that
define two partially redundant parallel pathways for the
engulfment process [4,5]. These pathways may be
conserved across evolution, as two other engulfment
genes have human homologues. A CED-5 homologue is
part of a human CrkII–DOCK180–Rac signaling pathway
proposed to mediate cytoskeletal reorganization [6–8]
and a CED-7 homologue is similar to the ABC
transporters [9,10]. Here, we report the cloning and
characterization of human CED-6, a human homologue
of C. elegans CED-6. The 34 kDa hCED-6 protein is
expressed in most tissues, some human cancer cells, and
in primary human macrophages. We developed an assay
that quantitates the phagocytic activity of mammalian
macrophages: the number of apoptotic cells that have
been internalized is measured by the uptake of
lacZ-positive apoptotic cells by adherent transgenic
macrophages. The results of this assay demonstrate that
overexpression of hCED-6 promotes phagocytosis only
of apoptotic cells and suggest that hCED-6 is the
mammalian orthologue of C. elegans CED-6 and is a part
of a highly conserved pathway that specifically mediates
the phagocytosis of apoptotic cells.
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Results and discussion
Human CED-6, the human homologue of C. elegans ced-6,
is located on chromosome 2, region q32.2–q33. The
hCED-6 protein (304 amino acids) contains a putative
phosphotyrosine-binding (PTB) domain at its amino ter-
minus, a positively charged region and a carboxy-terminal
serine/proline-rich region (Figure 1a). It is structurally
similar to C. elegans CED-6 (492 amino acids) and
Drosophila melanogaster CED-6 (517 amino acids;
Figure 1b). The sequence of the latter was obtained from
overlapping expressed sequence tags (ESTs). Interest-
ingly, hCED-6 shows the highest homology to the other
two proteins in the amino-terminal region, and the
carboxy-terminal part (downstream of the serine/proline-
rich region) is absent (Figure 1c). Although the PTB
domain was initially thought to end at Asp194, it might
extend further, including part of the predicted coiled-coil
region, which is clearly conserved among the three
species. Several PTB-domain-containing proteins, such as
Shc, Sck, Numb, FE65, Disabled, DOC-2, P96 and IRS-1,
have been found to act as adaptor molecules in signal
transduction pathways [11]. This might be achieved by
their ability to bind to phosphorylated tyrosines on acti-
vated receptors and/or phospholipids, and by their recruit-
ment of downstream molecules to form a signalling
complex [12]. The interaction of hCED-6 with candidate
receptors remains to be determined. 
The expression of hCED-6 mRNA was examined by both
northern blotting and reverse-transcriptase (RT)–PCR.
CED-6 is widely expressed in human tissues and human
cancer cell lines (Figure 2). The transcript size determined
by northern blotting was 3.2 kb, confirming the size esti-
mated from cDNA length. Expression of hCED-6 was also
detected by RT–PCR in primary human macrophages (data
not shown). Savill et al. [13] have previously shown that
neighbouring cells such as glomeral mesangial cells also
function in clearance of apoptotic neutrophils in the kidney.
The CED-6 signal might also be present in most human
cells that act as phagocytes and in professional phagocytes
of the macrophage line, as well as in tumour cells. 
To determine whether the function of hCED-6 in the
clearance of apoptotic cells is conserved in mammals, we
developed an assay that quantitates the phagocytic activity
of mammalian macrophages by automatically measuring
the number of apoptotic cells that have been internalized.
The presently known technique for quantitating the
phagocytosis of apoptotic cells is based on time-consuming
microscopic counting of the number of apoptotic cells
inside phagocytes [14]. There is thus a need for a reliable
and reproducible method that does not require scoring by
visual inspection and is therefore more suitable for use in
automated medium- and high-throughput screening. In
our assay, mouse J774 macrophages in 96-well plates were
challenged with apoptotic mouse Ba/F3 pre-B cells stably
transfected with the reporter gene lacZ, which encodes β-
galactosidase. Apoptosis of Ba/F3 cells was induced by
growth-factor withdrawal 20 hours before the assay [15].
These were optimized conditions, during which 20–30%
of the Ba/F3 cells are annexin-V-positive and less than 5%
are propidium-iodide-positive, showing that they are in the
early stages of apoptosis [16] (data not shown). After
washing the non-ingested apoptotic cells away, fluorescein
di-β-D-galactopyranoside, a fluorogenic substrate for
β-galactosidase, was added. Green fluorescence intensity
was measured with an automatic plate reader using 480 nm
excitation and 520 nm emission.  This phagocytosis assay
was validated by showing that exclusively engulfed apop-
totic cells were measured (see Supplementary material).
As shown in Figure 3a, the uptake of apoptotic cells by
J774 macrophages transfected with hCED-6 is 40–50%
(p < 0.005) higher than uptake by J774 cells or J774 cells
transfected with the empty vector. CD36 is one of the
adhesion molecules on the surface of macrophages that has
been implicated in the clearance of apoptotic cells [17,18].
1352 Current Biology Vol 9 No 22
Figure 1
Current Biology   
GGTGATGAGCCCTTGGGTTCTCGCTCCGACTGCTAAATTCGCTTGGCCGGGTCCACCTTC   60
TCGTGGCCTCACTCGCCACACGGATCAGAATCCGGAGCAGGCAGTTCTCTCTATTCTGAG  120
GCTCCTGCGGCTGCCGCGCTGACTTCCCTGTGTGGNGGAGGGAACTCTGGGCAGGCTGGT  180
TTTCTTGGAATGTGTTTACGATGTTGAATGGGACTTGAACAGGAAGCTGGACGCTGCAGC  240
TGGAACTAGCGTGCCAAGTTATTTATGATTCCATCTGATATACATAGGAGAGAAACTGAT  300
GAAGAATTCTGATGGCAACTGTATGATAGAAGCTATATAAAGTCAAGTGTCCATTTTCTT  360
TCAACTATATTTGAGCATACCCAGGATTTAAGTCGTGGAACTGAACATTTATTTGGCTGA  420
         M  N  R  A  F  S  R  K  K  D  K  T  W  M  H  T  P
TCCTCATCATGAACCGTGCTTTTAGCAGGAAGAAAGACAAAACATGGATGCATACACCTG  480
E  A  L  S  K  H  F  I  P  Y  N  A  K  F  L  G  S  T  E  V
AAGCTTTATCAAAACATTTCATTCCCTATAATGCAAAGTTTCTTGGCAGTACAGAAGTGG  540
E  Q  P  K  G  T  E  V  V  R  D  A  V  R  K  L  K  F  A  R
AACAGCCAAAAGGAACAGAAGTTGTGAGAGATGCTGTAAGGAAACTAAAGTTTGCAAGAC  600
H  I  K  K  S  E  G  Q  K  I  P  K  V  E  L  Q  I  S  I  Y
ATATCAAGAAATCTGAAGGCCAGAAAATTCCTAAAGTGGAGTTGCAAATATCAATTTATG  660
G  V  K  I  L  E  P  K  T  K  E  V  Q  H  N  C  Q  L  H  R
GAGTAAAAATTCTAGAACCCAAAACAAAGGAAGTTCAACACAATTGCCAGCTTCATAGAA  720
I  S  F  C  A  D  D  K  T  D  K  R  I  F  T  F  I  C  K  D
TATCTTTTTGTGCAGATGATAAAACTGACAAGAGGATATTCACTTTCATATGCAAAGATT  780
S  E  S  N  K  H  L  C  Y  V  F  D  S  E  K  C  A  E  E  I
CTGAGTCAAATAAACATTTGTGCTATGTATTTGACAGCGAAAAGTGTGCTGAAGAGATCA  840
T  L  T  I  G  Q  A  F  D  L  A  Y  R  K  F  L  E  S  G  G
CTTTAACAATTGGCCAAGCATTTGACCTGGCATACAGGAAATTTCTAGAATCAGGAGGAA  900
K  D  V  E  T  R  K  Q  I  A  G  L  Q  K  R  I  Q  D  L  E
AAGATGTTGAAACAAGAAAACAGATCGCAGGGTTACAAAAAAGAATCCAAGACTTAGAAA  960
T  E  N  M  E  L  K  N  K  V  Q  D  L  E  N  Q  L  R  I  T
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D  M  I  P  F  S  P  I  S  H  Q  S  S  M  P  T  R  N  G  T
ATATGATTCCATTTTCTCCAATATCACACCAGTCTTCGATGCCTACTCGCAATGGCACAC 1140
Q  P  P  P  V  P  S  R  S  T  E  I  K  R  D  L  F  G  A  E
AGCCACCTCCAGTACCTAGTAGATCTACTGAGATTAAACGGGACCTGTTTGGAGCAGAAC 1200
P  F  D  P  F  N  C  G  A  A  D  F  P  P  D  I  Q  S  K  L
CTTTTGACCCATTTAACTGTGGAGCAGCAGATTTCCCTCCAGATATTCAATCAAAATTAG 1260
D  E  M  Q  E  G  F  K  M  G  L  T  L  E  G  T  V  F  C  L
ATGAGATGCAGGAGGGGTTCAAAATGGGACTAACTCTTGAAGGCACAGTATTTTGTCTCG 1320
D  P  L  D  S  R  C  *
ACCCGTTAGACAGTAGGTGCTGACATCAAGAACAAGAAATCCTGATTCATGTTAAATGTG 1380
TTTGTATACACATGTCATTTATTATTATTACTTTAAGATAGGTATTATTCATGTGTCAAT 1440
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TTGTGTCTGAGTTCTATTTAGTTAGCATCTTGAAATTTGTATTCATTTTCCAGATGGCTA 1680
GTTTATTAATGATTTCCCAAAAGCCATACCTTAAAGATAACTTTTTAAATTCTGAAGAGA 1740
CATGCCAATGTCAAACTAAACATGTTCTGTTTTTAAACCAACAAACATGTTACTATTCAT 1800
TGGACAGATATCATTTTATGTATAAATACTGTTCACATCACTGGGAAAATGTAAACTTTA 1860
ACATAATGCCACAAGGTCACTAATTTCTAGCAGGTAAAATTATAAGGATATAAATTCCAA 1920
TAATAAACCAAATGTATTTAGAGTATTTATTAGTAAATGCAAGGTGATGTTAGTTATGAT 1980
CAGTTATACTCTAAATATTTAATTTGTTTTATAAAGGTAGTGAAAAAATGAAAATTTGCT 2040
ATTTATTAAAAAACATTAAATTTCATTCCAAATGAGATAAGTGATATTACTATAACATCT 2100
AAGCATCATCTGATTTGATATTCCCTAAAAAACATTTGGAATATATGCTATCTATAGATT 2160
CAGTATCTACTACCCATATTTACTTTACCAAATATATTTCTCCTCACTGCATAAGGACTA 2220
CTCTTCTCATATTTTCTTCTTTGATGAAGATATTTTTCACCAAAGTTTATTTTGTGATGC 2280
CCTCTTGGTTTTGATACTTTAAAATCTGTGGCACCCGTTCTACATGAATTATCAATATTT 2340
GGTAAATTCAATCTGTATTTGTTTTGTTAAAGTCAAAAATCTCATTTTCCAAAAAAAAAA 2400
AAAAAACCCAGTTACTGCTCAGTTTAGTCTTGAACATGAGCAATAAAATTCTCTTGCATT 2460
TCATTATTGATGTGCTGATGAACCTGGACTTTTAAAAATATTTGTTTCCTATACCTTTAC 2520
CCTTTACCTAACAGACTAATTTGTACTCAGTAAAACAAAAATTTATGGTCAAAATTTCTA 2580
ACTTGGTTCATCACATTATAAGATAAATAAATTAAATTAATGAAAATGTGACTTAGAGTA 2640
GGGGTAGCCCTCAAAAATAGATTTATCATTTACTCATTGGAATTTTCTTCAAGTGTTAAA 2700
GGTACATTTTCACTAGGAAAAGAAATCAAATATGCTTATGCAATATATATTTGTGTGTTT 2760
TTCCTTAATGTTATATGGTATATATGAGCCTTCTTGTTTAGTTTCTTTTATCTGCTAAGT 2820
TGTACCTTAATTAGAGGGCAATATATGTTTCATAAAGAAGAGTCTTTATAATTTTGTTTG 2880
TCAGATAGTATTTTGGAATTTGTATAATAAGGATGTTTAGAAGCCATATAAGTGGCTTTT 2940
TTTAACAGATAGAATTTGTATTTTTATTGTACTTTAAAAAGATTTATGTAATAGGTATAT 3000
ATTTAGTGGCCATTTATTATCAATGGTAACACAATGGAGTACTAAGATGGTATTTGCACA 3060
TTTAAGATATGTTACTTTACCAATTTTTAATGGTAATCAACTCTGCTACTGGCATGATGA 3120
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Structural characterization of human CED-6 (GenBank accession
number AF191771). (a) Consensus cDNA sequence (3.2 kb) and
protein sequence (molecular weight 34.4 kDa) of human CED-6.
Protein domains are marked as follows: double underline, PTB domain;
dashed underline, positively charged region; single underline,
serine/proline-rich region; bold, start and stop codons. (b) A multiple
alignment of hCED-6 (hsCED-6) with D. melanogaster and C. elegans
CED-6 [3] (drCED-6 and ceCED-6, respectively). Black and grey
boxes indicate identical and similar amino acids, respectively.
(c) Schematic structure of human, D. melanogaster and C. elegans
CED-6 [3]. The PTB domain, positively charged region and
serine/proline-rich domain are indicated; aa, amino acids. 
J774 macrophages transfected with CD36 were used as a
specific positive control in our phagocytosis assay of apop-
totic cells and were shown to have an 80% (p < 0.001)
higher uptake than the control macrophages. We then
explored whether overexpression of hCED-6 affected
phagocytosis in general or specifically enhanced the
engulfment of apoptotic cells. We found that viable cells
from the Ba/F3 cell line failed to interact with
macrophages in our assay (Figure 3b). Also, there was no
difference in phagocytosis of labelled Escherichia coli
between control J774 cells and J774 cells stably trans-
fected with hCED-6 and CD36 (Figure 3c). These results
suggest that hCED-6 specifically mediates phagocytosis of
apoptotic cells. 
In conclusion, we have demonstrated that hCED-6 is an
orthologue of C. elegans ced-6, as it is structurally and func-
tionally conserved across evolution. The most obvious
sequence feature of hCED-6 is a highly conserved PTB
domain, which strongly suggests that transduction of the
engulfment signal within the macrophage involves tyro-
sine phosphorylation. Furthermore, we established a func-
tional requirement for hCED-6 during the phagocytosis
process in mammals, which appears to be specific to apop-
totic cells. We suggest that CED-6 is involved in a
pathway for clearance of the apoptotic bodies that is con-
served through evolution, and that there is a common mol-
ecular mechanism responsible for the engulfment of
apoptotic cells in all metazoans. 
Supplementary material
Additional methodological details and a figure showing validation of the
mammalian assay for phagocytosis of apoptotic cells are available at
http://current-biology.com/supmat/supmatin.htm.
Acknowledgements
We thank M. Hengartner, S. Cornelis, J. Savill and K. Ravichandran for
their advice and E. Verheugen, N. Cromheecke and M. Brunain for 
technical assistance.
Brief Communication 1353
Figure 2
Expression pattern of human CED-6 in normal human tissues and
cancer cell lines. (a) Human multiple tissue MTN-1 blot (Clontech)
containing RNA from heart, brain, placenta, lung, liver, skeletal muscle,
kidney and pancreas. (b) Human multiple tissue MTN-II blot (Clontech)
containing RNA from spleen, thymus, prostate, testis, ovary, small
intestine, colon (mucosal lining) and peripheral blood leukocytes. 
(c) Blot of RNA from human cancer cell lines: HL-60, promyelocytic
leukaemia; S3, HeLa cells; K-562, chronic myelogenous leukaemia;
MOLT-4, lymphoblastic leukaemia; Raji, Burkitt’s lymphoma; SW48,
colorectal adenocarcinoma; A549, lung carcinoma; G361, melanoma.
All blots were hybridized with a human CED-6 probe. The transcript
size determined by northern blotting was 3.2 kb, confirming that
estimated from cDNA length.
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Functional characterization of human CED-6 in a new mammalian
phagocytosis assay. Phagocytosis of (a) apoptotic Ba/F3 cells, (b) live
Ba/F3 cells, and (c) E. coli by J774 macrophages that were left
untransfected or stably transfected with plasmids encoding enhanced
green fluorescent protein (EGFP), EGFP fused to human CED-6, and
EGFP fused to human CD36 (see Supplementary material). EGFP was
used to check transfection efficiency; the weak EGFP signal in
transfected macrophages did not interfere with the fluorescence
readout of the phagocytosis assay (data not shown). Fluorescence
intensity is proportional to the number of macrophages that had
ingested β-galactosidase-expressing Ba/F3 cells or that had ingested
fluorescein-labelled E. coli. Data are expressed as the mean ± standard
error of the mean (n = 24). Comparison with uptake by J774 cells:
**, p < 0.005, ***, p < 0.001.
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Supplementary material and methods
Cloning
NCBI database searches using the BLAST algorithm detected
several ESTs with statistically significant similarities to C. elegans
CED-6 (GenBank accession numbers AA159394, R76378,
THC117484, R65982, AA369714, R65983, D82787, AA443368,
AA431995, R33389, R53881 and H03749). By using overlapping
PCR with the primers 5′-GCATACACCTGAAGCTTTATCAAAAC-3′
and 5′-GATTTCTTGATATGTCTTGCAAACT-3′ on AA159394 and
5′-AGTTTGCAAGACATATCAAGAAATC-3′ and 5′-CAAATGCTTG-
GCCAATTGTTAAAGTGATCTCTTCAGCACACTTTTCGCTGTCAA-
ATACATAG-3′ on R76378, we were able to reconstitute a full open
reading frame (see Figure 1a). This sequence was further verified by
5′ rapid amplification of cDNA ends and colony hybridisation. The D.
melanogaster homologue was identified using both C. elegans CED-
6 and human CED-6 in database searches. Subsequently, two D.
melanogaster ESTs, LD20509 (GenBank accession number
AA540723) and LD09044 (AA390841), were sequenced and
aligned. The cDNA fragment containing the full length sequence of
hCED-6 was subcloned into the pEGFP-n3 eukaryotic expression
vector (Clontech) cut with BglII and SalI.
CD36 (GenBank accession number M98399) was amplified from a
placenta cDNA library with primer 5′-CGGACTCAGATC-
TATGGGCTGTGACCGGAACTGT-3′, which was designed to have
a BglII restriction site, and primer 5′-GCGGTACCGTCGACTTTTAT-
TGTTTTCGATCTGCATGCAC-3′, which has a SalI site. The ampli-
fied fragment including the full-length sequence of CD36 was
subcloned into the pEGFP-n3 eukaryotic expression vector cut with
BglII and SalI. 
Cell culture
The J774A.1 mouse monocyte-derived macrophage cell line (American
Type Culture Collection code TIB67) was maintained in Dulbecco’s
modified Eagle’s medium (DMEM, Life Technologies) supplemented
with 10% Myoclone super plus fetal bovine serum (Life Technologies).
The growth factor interleukin-3 (IL-3)-dependent murine Ba/F3 pre-B-
cell line was cultured as described previously [S1]. 
Northern blotting
Human multiple tissue northern blots MTN-1 and MTN-II (Clontech),
which contain in each lane 2 µg poly-A+ RNA from a different human
tissue or cancer cell line, were hybridized with a hCED-6
probe comprising the open reading frame according to the manufac-
turer’s instructions. 
RT–PCR
Human primary macrophages were isolated and cultured as described
previously [S2]. RNA was isolated from human primary macrophages
using the RNeasy mini kit (Qiagen). Starting from this RNA, first-strand
cDNA was generated using the Ready-To-Go T-primed first-strand kit
(Pharmacia Biotech). PCR was performed with primers 5′-CGCAAG-
GATCCCCATGAACCGTGCTTTTAGCAGGAAG-3′ and 5′-GATC-
TACTAGGTACTGGAG-3′ followed by nested PCR with primers
5′-CGCAAGGATCCCCATGAACCGTGCTTTTAGCAGGAAG-3′ and
5′-GCGGATGGTACCGTCGACTGCTGATACTTGAGTTATTCTCAG-
3′. PCR products were analyzed on agarose gels and subsequently
purified, cloned and sequenced.
Transfection
J774 cells were transfected with the plasmids pEGFP-n3 (Clontech),
human full length CED-6 cloned into the multicloning site of pEGFP-
n3, and human full length CD36 cloned into the multicloning site of
pEGFP-n3. Double-pulse electroporation of 3 × 106 cells and 30 µg
DNA was performed with Easyject Plus electroporator system
(Equibio). Electroporation parameters for the first and second pulse
were, respectively, a voltage of 750 V and 150 V; a capacitance of
25 and 1500 µF; and a resistance of 99 Ω for both pulses. Clones
were selected after 72 h with 400 µg/ml G418 antibiotic (Duchefa),
and checked for GFP expression. The weak GFP expression of trans-
fected macrophages did not interfere with the fluorescence readout of
the phagocytosis assay (data not shown). Ba/F3 cells were transfected
by electroporation as described previously [S3].
Phagocytosis assays
Parental or stably transfected J774 cells (1 × 105) were dispensed into
96-well plates (Costar) 36 h before phagocytosis assays. Ba/F3 cells
that had been deprived of IL-3 by washing three times in IL-3-free
medium 20 h before phagocytosis assays were used as a source of
apoptotic cells. Ba/F3 cells cultured in the presence of IL-3 were taken
as a control.
Ba/F3 cells (1 × 106) in 100 µl DMEM were overlaid onto wells of
macrophages. After 1 h incubation at 37°C in 5% CO2, wells were
washed three times with PBS (Life Technologies). Fluorescein di-β-D-
galactopyranoside (Molecular Probes; 10 µM) was added to each well
and the plates were incubated in the dark for 1 h at room temperature.
Microscopic analysis showed Ba/F3 cells phagocytosed by J774 cells.
Green fluorescence intensity was measured with an automatic fluores-
cence plate reader Victor 2 (Wallac) using 480 nm excitation and
520 nm emission.
Supplementary material
Figure S1
Validation of the phagocytosis assay of apoptotic cells. Phagocytosis
of apoptotic Ba/F3 cells and live Ba/F3 cells by J774 macrophages
and J774 macrophages fixed with 3.7% formaldehyde to discriminate
between mere binding and active engulfment of apoptotic cells.
Fluorescence intensity is proportional to the number of macrophages
that had ingested β-galactosidase-expressing Ba/F3 cells. Data are
expressed as the mean ± standard error of the mean (n = 7).
Comparison with uptake by J774 cells: ***, p < 0.001.
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